Soluble CD30 in normotensive pregnant women with isolated fetal intrauterine growth restriction: A comparison with preeclamptic women

Journal of Reproductive Immunology

Volumn 86, Issue 2, 2010, Pages 122-125

  Laskowska, Marzena ^a   Laskowska, Katarzyna ^a   Oleszczuk, Jan ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Intrauterine fetal growth restriction (IUGR); Preeclampsia; SCD30

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LYMPHOCYTE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD30; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 77957272379     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.05.004     Document Type: Article

References (10)

1. Bretelle F., Sabatier F., Blann A., D'Ercole, Boutiere B., Mutin M., Boubli L., Sampol J., Dignat-George F. Maternal endothelial soluble cell adhesion molecules with isolated small for gestational age fetuses; comparison with preeclampsia. Br. J. Obstet. Gynaecol. 2001, 108:1277-1282.
2. Clark E.A., Ledbetter J.A. How B and T cells talk to each other. Nature 1994, 367:425.
3. Ekström E.S., Bengtsson A., Svensson A., Nilsson C., Ostlund E., Sandstedt B., Bremme K., Lilja G., Scheynius A. Presence of CD30+ and CD30L+ cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy. Placenta 2001, 22:372-379.
4. Eskenazi B., Fenster L., Sidney S., Elkin E.P. Fetal growth retardation in infants of multiparous women with preeclampsia. Am. J. Obstet. Gynecol. 1993, 169:1112-1118.
5. Gharesi-Fard B., Zolghadri J., Tavazzoo F. Soluble CD30 (sCD30) in normal pregnancy, preeclampsia and recurrent spontaneous abortion (RSA). J. Reprod. Immunol. 2009, 81:164. (Abstract P26).
6. Hammann D., Hilkens C.M.U., Grogan J.L., Lens S.M.A., Kapsenberg M.L., Yazdanbakhsh M., van Lier R.A.W. CD30 expression does not discriminate between human Th1- and Th2-type T cells. J. Immunol. 1996, 156:1387-1391.
7. Kusanovic J.P., Romero R., Hassan S.S., Gotsch F., Edwin S., Erez O., Mittal P., Mazaki-Tovi S., Soto E., Than N.G., Friel L.A., Chaiworapongsa T., Yoon B.H., Espinoza J. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J. Matern. Fetal Neonatal. Med. 2007, 20(12):867-878.
8. Newhouse S.M., Davidge S.T., Winkler-Lowen B., Demianczuk N., Guilbert L.J. In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without preeclampsia. Placenta 2007, 28:999-1003.
9. Roberts J.M., Lain K.Y. Recent insights into the pathogenesis of preeclampsia. Placenta 2002, 23:359-372.
10. Saito S., Shiozaki A., Sasaki Y., Nakashima A., Shima T., Ito M. Regulatory cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin. Immunopathol. 2007, 29:115-122.